Providence Capital Advisors, LLC Quest Diagnostics Inc Transaction History

Providence Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$123.78 - $142.11 $977,862 - $1.12 Million	7,900 Added 22.19%	43,509 $5.79 Million
Q3 2023 Nov 13, 2023	BUY	$121.86 - $144.92 $134,046 - $159,412	1,100 Added 3.19%	35,609 $4.34 Million
Q2 2023 Aug 10, 2023	BUY	$130.56 - $146.84 $508,400 - $571,794	3,894 Added 12.72%	34,509 $4.85 Million
Q1 2023 May 17, 2023	SELL	$131.53 - $155.76 $566 Million - $670 Million	-4,300,795 Reduced 99.29%	30,615 $4.33 Million
Q1 2023 May 17, 2023	BUY	$131.53 - $155.76 $569 Million - $674 Million	4,328,459 Added 146677.7%	4,331,410 $613 Million
Q1 2023 May 10, 2023	SELL	$131.53 - $155.76 $3.41 Million - $4.04 Million	-25,949 Reduced 89.79%	2,951 $417,000
Q4 2022 Feb 07, 2023	BUY	$123.31 - $157.26 $3.56 Million - $4.54 Million	28,900 New	28,900 $4.52 Million
Q2 2020 Aug 04, 2020	SELL	$73.34 - $122.61 $7,334 - $12,261	-100 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$75.14 - $115.68 $7,514 - $11,568	100 New	100 $8,000

933

93.8M

501K

238K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Providence Capital Advisors, LLC with notifications on news.